Author/Authors :
Abimiku, Alash’le Institute of Human Virology Nigeria - Abuja, Nigeria , Croxton, Talishiea Institute of Human Virology Nigeria - Abuja, Nigeria , Agala, Ndidi Institute of Human Virology Nigeria - Abuja, Nigeria , Jonathan, Emmanuel Institute of Human Virology Nigeria - Abuja, Nigeria , Balogun, Olasinbo Institute of Human Virology Nigeria - Abuja, Nigeria , Ozumba, Petronilla J. Institute of Human Virology Nigeria - Abuja, Nigeria , Onyemata, Enzenwa Institute of Human Virology Nigeria - Abuja, Nigeria , Lawal, Shefiya Department of Internal Medicine - University of Abuja Teaching Hospital - Abuja, Nigeria , Mamven, Manmak Department of Internal Medicine - University of Abuja Teaching Hospital - Abuja, Nigeria , Ajayi, Samuel Department of Medicine - University of Abuja Teaching Hospital - Abuja, Nigeria , Melikam, Sylvia E. Department of Medicine - University of Ibadan - Ibadan, Nigeria , Owolabi, Mayowa Center for Genomic and Precision Medicine- College of Medicine - University of Ibadan - Ibadan, Nigeria , Ovbiagele, Bruce Department of Neurology - University of Ghana Medical School - Accra, Ghana , Adu, Dwomoa Department of Neurology - Medical University of South Carolina - Charleston - South Carolina, United States , Ojo, Akinlolu Department of Internal Medicine - University of Michigan - Ann Arbor - Michigan, United States , Beiswanger, Christine M. Independent Contractor - Philadelphia - Pennsylvania, United States
Abstract :
The Institute of Human Virology Nigeria (IHVN) – Human Heredity and Health in Africa (H3Africa) Biorepository (I-HAB) seeks to provide high-quality biospecimens for research. This depends on the ability of clinical research sites (CRS) – who provide biospecimens – to operate according to well-established industry standards. Yet, standards are often neglected at CRSs located in Africa. Here, I-HAB reports on its four-pronged approach to empower CRSs to prepare high-quality biospecimens for research.
Objectives
I-HAB sought (1) to assess a four-pronged approach to improve biobanking practices and sample quality among CRSs, and (2) to build human capacity.
Methods
I-HAB partnered with two H3Africa principal investigators located in Nigeria and Ghana from August 2013 through to May 2017 to debut its four-pronged approach (needs assessment, training and mentorship, pilot, and continuous quality improvement) to empower CRSs to attain high-quality biospecimens.
Results
Close collaborations were instrumental in establishing mutually beneficial and lasting relationships. Improvements during the 12 months of engagement with CRSs involved personnel, procedural, and supply upgrades. In total, 51 staff were trained in over 20 topics. During the pilot, CRSs extracted 50 DNA biospecimens from whole blood and performed quality control. The CRSs shipped extracted DNA to I-HAB and I-HAB that comparatively analysed the DNA. Remediation was achieved via recommendations, training, and mentorship. Preanalytical, analytical and post-analytical processes, standard operating procedures, and workflows were systematically developed.
Conclusion
Partnerships between I-HAB and H3Africa CRSs enabled research sites to produce high-quality biospecimens through needs assessment, training and mentorship, pilot, and continuous monitoring and improvement.
Keywords :
biotechnology , biobank , training , Africa , developing country